Arthrosamid Safety, Pain Relief Duration: New Non-Surgical OA Treatment Report

In their latest report, the London specialists in musculoskeletal care and regenerative medicine explain that Arthrosamid offers a promising alternative to traditional treatments, with a favorable safety profile and the potential for long-term relief from a single injection.

More information about Arthrosamid for osteoarthritis, and options for booking a consultation at MSK Doctors without a GP referral can be found at https://mskdoctors.com/treatments/arthrosamid

Osteoarthritis affects millions of people worldwide, leading to pain, stiffness, and difficulty with mobility, but to date, there is no long-term solution. Traditional treatments for osteoarthritis knee pain often focus on managing symptoms, such as pain medication and physical therapy, however, these treatments do not address the underlying cause of the condition and may not provide long-term relief.

Arthrosamid utilizes a unique approach to treating osteoarthritis knee pain that combines a traditional technique with new and innovative material, leading to the only treatment available today with the potential for lasting pain relief. It is a single injection which lubricates and cushions the joint, similar to several other popular treatments, but using a non-biodegradable polymer.

While traditional knee injection treatments are known to last for weeks or months, before they are absorbed by the body and become less effective, Arthrosamid cannot be absorbed by the body. This allows the treatment to continue acting as a cushion and lubrication for the knee joint for several years or longer, from a single injection.

Clinical studies have shown that Arthrosamid has a favorable safety profile, with no long-lasting adverse events reported. While some side effects may be possible, the most commonly reported issues were both minor and temporary, such as short-term swelling or itching at the injection site.

Although this treatment is new at most clinics, Arthrosamid has been extensively tested for over 20 years in clinical trials with no major complications. It has also been administered in local clinics by select, chosen medical professionals, before being more publicly approved for use in the UK.

Prof. Paul Lee, founder of the MSK Doctors clinic, is one of the first UK clinicians to be approved to provide Arthrosamid. Appointments are available to all individuals, including new patients with no GP referral, for consultation, diagnosis, or treatment.

More information about Arthrosamid clinical testing, duration, and appointments can be found in the full report, at https://mskdoctors.com/treatments/arthrosamid

MSK Doctors

MSK House London Road
Silk Willoughby, Sleaford, Lincolnshire
Sleaford
England
NG34 8NY
United Kingdom